Dominari Holdings Inc. (DOMH)
Largest Insider Buys in Sector
DOMH Stock Price History Chart
DOMH Stock Performance
About Dominari Holdings Inc.
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
Insider Activity of Dominari Holdings Inc.
Over the last 12 months, insiders at Dominari Holdings Inc. have bought $151,025 and sold $0 worth of Dominari Holdings Inc. stock.
On average, over the past 5 years, insiders at Dominari Holdings Inc. have bought $231,109 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hayes Anthony (CEO) — $120,250. Wool Kyle Michael (President) — $90,901.
The last purchase of 3,482 shares for transaction amount of $8,357 was made by Hayes Anthony (CEO) on 2024‑05‑30.
List of Insider Buy and Sell Transactions, Dominari Holdings Inc.
| 2024-05-30 | CEO | 3,482 0.0788% | $2.40 | $8,357 | -17.76% | |||
| 2024-05-29 | CEO | 1,158 0.0246% | $2.25 | $2,606 | -22.47% | |||
| 2024-05-29 | President | 5,000 0.1037% | $2.20 | $11,000 | -22.47% | |||
| 2024-04-08 | President | 8,500 0.2394% | $2.99 | $25,390 | -34.98% | |||
| 2024-04-05 | CEO | 13,500 0.366% | $2.88 | $38,823 | -41.40% | |||
| 2024-04-04 | CEO | 3,944 0.0975% | $2.62 | $10,339 | -34.34% | |||
| 2024-04-04 | President | 19,000 0.5139% | $2.87 | $54,511 | -34.34% | |||
| 2023-12-26 | COO | 7,000 0.1684% | $2.55 | $17,863 | -25.57% | |||
| 2023-12-26 | President | 5,000 0.1225% | $2.60 | $12,997 | -25.57% | |||
| 2023-12-20 | CEO | 70,000 1.3215% | $2.00 | $140,168 | -4.39% | |||
| 2023-12-12 | CEO | 4,000 0.0755% | $2.00 | $8,012 | +3.06% | |||
| 2023-12-12 | 4,000 0.0766% | $2.03 | $8,122 | +3.06% | ||||
| 2023-11-30 | COO | 1,000 0.0215% | $2.28 | $2,278 | -9.69% | |||
| 2023-11-28 | COO | 1,000 0.0213% | $2.26 | $2,259 | -9.29% | |||
| 2023-11-27 | 1,000 0.0207% | $2.20 | $2,200 | -5.96% | ||||
| 2023-11-24 | CEO | 1,481 0.0302% | $2.16 | $3,200 | -7.62% | |||
| 2023-11-22 | CEO | 1,323 0.0261% | $2.09 | $2,765 | 0.00% | |||
| 2023-11-20 | director | 2,000 0.0387% | $2.05 | $4,103 | +3.00% | |||
| 2023-11-16 | CEO | 2,500 0.0463% | $1.97 | $4,916 | +4.04% | |||
| 2023-11-14 | CEO | 2,500 0.0455% | $1.93 | $4,825 | +6.74% |
Insider Historical Profitability
| Hayes Anthony | CEO | 223146 3.5217% | $1.35 | 20 | 0 | <0.0001% |
| Wool Kyle Michael | President | 27750 0.438% | $1.35 | 22 | 0 | <0.0001% |
| Devall Christopher Franklin | COO | 30033 0.474% | $1.35 | 5 | 0 | <0.0001% |